Stefan Duensing

University Hospital Heidelberg, Heidelberg University

Papers

2

Total Citations

52

H-Index

2

About

Stefan Duensing is a leading urologic oncologist whose research centers on improving surgical outcomes for prostate cancer patients, with a particular focus on advanced imaging and salvage therapies. His work has been instrumental in refining how multiparametric magnetic resonance imaging (mpMRI) can predict extraprostatic extension and surgical margin status, helping to standardize risk stratification for low-, intermediate-, and high-risk prostate cancer. This influential 2015 study, cited 37 times, provides clinicians with a framework to better anticipate surgical challenges and optimize treatment planning. More recently, Duensing has been at the forefront of evolving salvage radical prostatectomy techniques, documenting the transition from open surgery to robotic and Retzius-sparing approaches. His 2021 analysis of these minimally invasive methods demonstrates improved continence outcomes and biochemical recurrence-free survival for patients with local recurrence. By systematically evaluating the oncological and functional benefits of each surgical evolution, Duensing has helped establish new standards for salvage therapy, offering renewed hope to patients facing recurrence after primary treatment.

Research Focus

Key Achievements

2
H-Index
2
Papers
52
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard
37 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University Hospital Heidelberg, Heidelberg University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago